Oral testosterone must be methylated as part of hormone therapy for women with reduced sexual desire, and may have negative metabolic effects compared with transdermal bioidentical testosterone.

Looking for smart, simple tips to help keep you healthy? Your Health is a free, monthly e-newsletter from Johns Hopkins Medicine.